Skip Navigation



Carcinogenesis Advance Access published online on March 26, 2007

Carcinogenesis, doi:10.1093/carcin/bgm072
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
28/8/1629    most recent
bgm072v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Zhang, H.
Right arrow Articles by Fan, C.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, H.
Right arrow Articles by Fan, C.-Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Targeting Human 8-Oxoguanine DNA Glycosylase (hOGG1) to Mitochondria Enhances Cisplatin Cytotoxicity in Hepatoma Cells

Haihong Zhang*, Takatsugu Mizumachi{dagger}, Jaime Carcel-Trullols{dagger}, Liwen Li*, Akihiro Naito{dagger}, Horace J. Spencer{ddagger}, Paul Spring, Bruce R. Smoller*, Amanda J. Watson#, Geoffrey P. Margison#, Masahiro Higuchi{dagger} and Chun-Yang Fan*,§

* From the Department of Pathology, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205
{dagger} From the Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205
{ddagger} From the Department of Biostatistics, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205
From the Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205
§ John L. McClellan Memorial Veterans Hospital, 4300 West 7th Street, Little Rock, AR 72205
# Division of Carcinogenesis, Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Withington, Manchester M20 4BX, United Kingdom

Correspondence to: Chun-Yang Fan, M.D., Ph.D., Department of Pathology (LR/113), University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, 4300 West 7th Street, Little Rock, AR 72205; Phone: 501 257-6469, Fax: 501 257-6430; email: fanchunyang{at}uams.edu

Many chemoradiation therapies cause DNA damage through oxidative stress. An important cellular mechanism that protects cells against oxidative stress involves DNA repair. One of the primary DNA repair mechanisms for oxidative DNA damage is base excision repair (BER). BER involves the tightly coordinated function of four enzymes (glycosylase, AP endonuclease, polymerase, ligase), in which 8-oxoguanine DNA glycosylase 1 (OGG1) initiates the cycle. An imbalance in the production of any one of these enzymes may result in the generation of more DNA damage and increased cell killing. In this study, we targeted mitochondrial DNA to enhance cancer chemotherapy by overexpressing a human OGG1 (hOGG1) gene in the mitochondria of human hepatoma cells. Increased hOGG1 transgene expression was achieved at RNA, protein, and enzyme activity levels. In parallel, we observed enhanced mitochondrial DNA damage, increased mitochondrial respiration rate, increased membrane potential, and elevated free radical production. A greater proportion of the hOGG1-overexpressing hepatoma cells experienced apoptosis. Following exposure to a commonly used chemotherapeutic agent, cisplatin, cancer cells overexpressing hOGG1 displayed much shortened long-term survival when compared to control cells. Our results suggest that overexpression of hOGG1 in mitochondria may promote mitochondrial DNA damage by creating an imbalance in the BER pathway and sensitize cancer cells to cisplatin. These findings support further evaluation of hOGG1 overexpression strategies for cancer therapy.

Key Words: hOGG1 • imbalanced base excision repair • mitochondria • free radical • chemotherapy


¥ These two authors contributed equally to the manuscript.

Received January 28, 2007; revised March 1, 2007; accepted March 19, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
T. J. Preston, J. T. Henderson, G. P. McCallum, and P. G. Wells
Base excision repair of reactive oxygen species-initiated 7,8-dihydro-8-oxo-2'-deoxyguanosine inhibits the cytotoxicity of platinum anticancer drugs
Mol. Cancer Ther., July 1, 2009; 8(7): 2015 - 2026.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. B. Meira, C. A. Moroski-Erkul, S. L. Green, J. A. Calvo, R. T. Bronson, D. Shah, and L. D. Samson
Aag-initiated base excision repair drives alkylation-induced retinal degeneration in mice
PNAS, January 20, 2009; 106(3): 888 - 893.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Jiang, C. Guo, M. R. Vasko, and M. R. Kelley
Implications of Apurinic/Apyrimidinic Endonuclease in Reactive Oxygen Signaling Response after Cisplatin Treatment of Dorsal Root Ganglion Neurons
Cancer Res., August 1, 2008; 68(15): 6425 - 6434.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.